Clopidogrel Acino European Union - English - EMA (European Medicines Agency)

clopidogrel acino

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome., ,

RIVASTIGMINE ACINO 4.6 mg/24 hours Transdermal Patch Ireland - English - HPRA (Health Products Regulatory Authority)

rivastigmine acino 4.6 mg/24 hours transdermal patch

acino ag - rivastigmine - transdermal patch - 4.6 mg/24 hours

RIVASTIGMINE ACINO 9.5 mg/24 hours Transdermal Patch Ireland - English - HPRA (Health Products Regulatory Authority)

rivastigmine acino 9.5 mg/24 hours transdermal patch

acino ag - rivastigmine - transdermal patch - 9.5 mg/24 hours

Tadalafil Acino 5 mg film-coated tablets Malta - English - Medicines Authority

tadalafil acino 5 mg film-coated tablets

acino ag im windfeld 35, miesbach, 83714, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals

Tadalafil Acino 20 mg film-coated tablets Malta - English - Medicines Authority

tadalafil acino 20 mg film-coated tablets

acino ag im windfeld 35, miesbach, 83714, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals

Clopidogrel Acino Pharma European Union - English - EMA (European Medicines Agency)

clopidogrel acino pharma

acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.

Clopidogrel Acino Pharma GmbH European Union - English - EMA (European Medicines Agency)

clopidogrel acino pharma gmbh

acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.

ANTOX 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

antox 500 mg comprimidos recubiertos con pelicula

acino pharma ag - ciprofloxacino (hidrocloruro) - ciprofloxacino (hidrocloruro)....500.00 mg

CIPROFLOXACINO NORMON 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

ciprofloxacino normon 500 mg comprimidos recubiertos con pelicula efg

laboratorios normon, s.a. - ciprofloxacino (hidrocloruro) - ciprofloxacino (hidrocloruro)....500mg

LEVOFLOXACINO (HEMIHIDRATO) 500MG TABLETAS RECUBIERTAS Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

levofloxacino (hemihidrato) 500mg tabletas recubiertas

laboratorios stein, s.a. - levofloxacino (hemihidrato) - levofloxacino (hemihidrato)....500 mg